Quick answer: The Omega-3 Index is a blood test that measures how much of two omega-3 fats, EPA and DHA, is built into the membranes of your red blood cells. Because red blood cells live for about four months, it reflects your intake over the past few months rather than your last meal. In large observational studies, people with higher levels tended to live longer, and a randomized trial showed that the number rises in a predictable way when EPA and DHA intake goes up.
Key takeaways
The Omega-3 Index measures how much EPA and DHA has been built into the membranes of your red blood cells, so it reflects your intake over the past few months rather than your most recent meal.
Large observational studies, including a pooled analysis of 17 long-term cohorts and the Framingham Offspring data, found that people with higher levels tended to live longer. These studies show a link rather than proof of cause, which is why the article walks through their limits.
A randomized trial found that the index rises in step with EPA and DHA intake, and that body weight and starting level shape how much it moves for each person. That is what makes it a useful way to replace guessing with a measurement.
Most people know that omega-3 fats from fish are considered good for the heart and brain. What fewer people know is that there is a simple way to see how much of these fats has actually made it into your body. Two people can eat what looks like the same diet and end up with very different omega-3 levels, and a supplement bottle on the counter tells you nothing about how much is reaching your cells. In this article, I want to explain what the Omega-3 Index measures, walk through four free, peer-reviewed studies that shaped how researchers think about it, and share how I use it as a functional medicine doctor.
What the Omega-3 Index actually measures
The Omega-3 Index is the combined amount of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in your red blood cell membranes, reported as a percentage of all the fatty acids in those membranes. EPA and DHA are the long-chain omega-3 fats found mainly in seafood such as salmon, sardines, mackerel, herring, and anchovies. They are different from alpha-linolenic acid (ALA), the shorter omega-3 found in flax, chia, and walnuts, which the body converts to EPA and DHA only in small amounts.
Researchers generally describe an index of 4 percent or lower as the high-risk range, 4 to 8 percent as intermediate, and 8 percent or higher as the range linked with the lowest risk. In studies of American adults who do not take omega-3 supplements, average values tend to fall between about 4 and 5 percent. Because the test looks at red blood cells instead of a single blood draw’s worth of floating fats, a fish dinner the night before has little effect on the result. That stability is a large part of what makes it useful.
A pooled look at 17 long-term studies
The largest study on this topic was published in Nature Communications in 2021 by William Harris and colleagues in the Fatty Acids and Outcomes Research Consortium. The team pooled data from 17 prospective cohort studies that together followed 42,466 people for a median of 16 years, during which 15,720 deaths occurred. After adjusting for other risk factors, people in the highest fifth of blood EPA, DHA, and a related fat called DPA had a 15 to 18 percent lower risk of dying from any cause during follow-up than those in the lowest fifth. Similar patterns showed up for deaths from cardiovascular disease, cancer, and other causes.
One detail I find telling is that the plant-based omega-3, ALA, showed no relationship with mortality in this analysis. The association was specific to the long-chain fats that come mostly from seafood. This was an observational study, so it shows a link rather than proof that raising omega-3 levels extends life, but its size and length make it hard to ignore. You can read the free full text on PubMed Central.
What the Framingham Offspring data showed
An earlier analysis from the Framingham Heart Study, published in the Journal of Clinical Lipidology in 2018, looked at the Omega-3 Index directly. Researchers measured it in 2,500 adults with an average age of 66, then followed them for a median of about seven years. After adjusting for 18 other variables, people in the highest fifth, with an index above 6.8 percent, had a 34 percent lower risk of death from any cause and a 39 percent lower risk of a new cardiovascular event than people in the lowest fifth, whose index was below 4.2 percent.
The authors also compared the Omega-3 Index with total cholesterol in the same statistical models. In that comparison, the Omega-3 Index was significantly related to the outcomes, while total cholesterol was not. The authors noted that the follow-up was relatively short and that the index was measured only once, which are fair limitations to keep in mind. The full text is free on PubMed Central.
A link with brain volume later in life
Omega-3 fats are not only a heart topic. DHA makes up a large share of the fatty acids in the brain’s gray matter, so researchers have also asked whether blood levels relate to brain structure as we age. In a 2014 study published in Neurology, James Pottala and colleagues measured red blood cell EPA and DHA in 1,111 postmenopausal women in the Women’s Health Initiative Memory Study and then looked at MRI brain scans taken about eight years later.
Women with a higher Omega-3 Index had larger total brain volume and larger volume in the hippocampus, a region central to memory that tends to shrink with age. Each 1 standard deviation higher index was linked with about 2.1 cubic centimeters more total brain volume after adjusting for other factors. Women in the top quarter of the index had about 159 cubic millimeters more hippocampal volume than women in the bottom quarter. Like the other studies here, this one shows an association rather than cause and effect, and the authors called for future research to test whether keeping levels higher actually slows brain shrinkage. You can read it on PubMed Central.
How much the number can change
The most practical study in this group is a randomized, placebo-controlled trial published in the Journal of the American Heart Association in 2013 by Mary Flock, Penny Kris-Etherton, and colleagues. They assigned 115 healthy adults between 20 and 45 years old to one of five daily doses of EPA and DHA, ranging from none to 1,800 milligrams, for about five months. At the start, the average Omega-3 Index was 4.3 percent, which falls in the low range.
The index rose in step with the dose. In the highest-dose group, it climbed on average from 4.3 percent to 9.5 percent. The dose alone explained about two thirds of the change, and adding body weight, starting level, age, sex, and physical activity explained even more. People with lower body weight tended to see a larger rise from the same amount, which is one reason a single standard dose does not fit everyone. The authors concluded that the Omega-3 Index is a valid marker of EPA and DHA intake. One limitation is that everyone in the trial was a healthy adult aged 20 to 45, so the response may differ in older adults or people with health conditions, and the study measured the blood marker rather than health outcomes. The free full text is on PubMed Central.
Where the evidence is still unsettled
It is worth being clear about what these studies do and do not show. The mortality and brain findings come from observational research, which can reveal strong patterns but cannot rule out that people with higher omega-3 levels also differ in other healthy ways. Large randomized trials of fish oil supplements have had mixed results, and the authors of the 2021 pooled analysis describe the topic as controversial for that reason. Omega-3 supplements can also interact with blood-thinning medications and are not the right choice for everyone. What the evidence does support well is that the Omega-3 Index reflects real intake and responds when intake changes.
How I use the Omega-3 Index in practice
For me, the value of this test is that it replaces guessing with a measurement. Some people who eat fish regularly already have a healthy level, while others who take a capsule every day are still in the low range. Checking the index gives us a starting point, helps us decide whether food changes are enough, and lets us recheck after three to four months to see whether the plan is working. It can be measured from a standard blood draw, and some labs offer it from a finger-prick sample.
I look at it alongside other markers of cardiovascular and metabolic health rather than on its own. If you are curious about related tests, my articles on the ApoB test and the hs-CRP inflammation test explain two other numbers I often review. If you already know you would like to raise your level, my guides on who should consider omega-3s and how to take fish oil cover the practical details. For most people, the first step is simply eating fatty fish two or more times a week, and it is wise to talk with your clinician before adding a supplement, especially if you take medication that affects bleeding.
Curious whether your omega-3 level is where it should be?
Book a Free 15-Minute Consultation
A free 15-minute consultation with Dr. Kneessi. No cost, no obligation.
Questions to bring to your clinician
These questions can help you get the most out of your next visit.
Would checking my Omega-3 Index give us useful information, given how much seafood I eat right now?
If my number comes back in the low range, would you start with food changes, or does a supplement make sense for me?
Do any of my medications, especially ones that affect bleeding, change whether omega-3s are a good fit for me?
When would you want to recheck my level, and which other heart and metabolic markers should we review alongside it?
Frequently asked questions
Is the Omega-3 Index part of a regular cholesterol panel?
No. A standard lipid panel measures cholesterol and triglycerides, and it does not report the omega-3 content of your red blood cells. The Omega-3 Index is a separate test that usually has to be requested specifically.
What Omega-3 Index range do researchers consider desirable?
Researchers commonly describe 8 percent or higher as the range associated with the lowest risk and 4 percent or lower as the highest-risk range. In the Framingham analysis, people above 6.8 percent fared better than those below 4.2 percent, so even moving out of the lowest range appears to matter.
How long should I wait before rechecking my level?
Because red blood cells turn over about every four months, most clinicians wait around three to four months after a change in diet or supplements before retesting. In the 2013 dose-response trial, participants were followed for about five months, which gave their levels time to settle.
Can I raise my level with flax or chia seeds alone?
Flax, chia, and walnuts provide ALA, which the body converts to EPA and DHA only in small amounts. In the 2021 pooled analysis, ALA levels were not linked with mortality, so seafood or an algae-based source of EPA and DHA is usually the more direct way to change the Omega-3 Index.
Sources
This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before making changes to your diet, exercise, supplements, or medications, especially if you are pregnant, nursing, or managing a health condition.
Looking for practitioner-grade options?
The catalog carries third-party-tested, practitioner-grade supplements from brands Dr. Kneessi uses in practice.
See practitioner-grade options in the catalogNot sure what fits? Take the Supplement Quiz →Free: The 28-Day Reset for Energy and Focus
A simple day-by-day email guide to sleep, movement, food, and daily habits that support healthy aging. It’s free, and you can unsubscribe anytime.
Get the free guide Take the supplement quiz
